Article Information
History
- October 14, 2021.
Article Versions
- Version 1 (May 17, 2021 - 09:32).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Philipe Gobeil1,
- Stéphane Pillet1,
- Iohann Boulay1,
- Annie Séguin1,
- Alexander Makarkov1,
- Gretchen Heizer1,
- Kapil Bhutada1,
- Asif Mahmood1,
- Nathalie Charland1,
- Sonia Trépanier1,
- Karen Hager1,
- Julia Jiang-Wright1,
- Judith Atkins1,
- Matthew P. Cheng2,
- Donald C. Vinh2,
- Philippe Boutet3,
- François Roman3,
- Robbert Van Der Most4,
- Maria Angeles Ceregido3,
- Marc Dionne5,
- Guy Tellier6,
- Jean-Sébastien Gauthier7,
- Brandon Essink8,
- Michael Libman2,
- Jason Haffizulla9,
- André Fréchette10,
- Marc-André D’Aoust1,
- Nathalie Landry1,† and
- Brian J. Ward1,2,†,*
- 1Medicago Inc
- 2Research Institute of the McGill University Health Centre
- 3GlaxoSmithKline Biologicals SA (Vaccines)
- 4Coalition for Epidemic Preparedness Innovations
- 5CHU de Québec-Université Laval
- 6Manna Research (Mirabel)
- 7Q&T Research Sherbrooke Inc
- 8Meridian Clinical Research, LLC
- 9Precision Clinical Research
- 10Diex Research Quebec Inc
- ↵*Corresponding author: Brian Ward, 1020 Route de l’Église, Bureau 600, Québec, Qc, Canada, G1V 3V9; Tel. 418 658 9393; Fax. 418 658 6699; wardb{at}medicago.com
↵† These individuals are equally credited as senior authors.